Heidi Segers

9PUBLICATIONS
47CO-AUTHORS
Gene and molecular therapyHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 16, 2025
DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia.

Mathilde Rønne Koch, Anna Sofie Buhl Rasmussen, Bodil Als-Nielsen

|Aug 27, 2024
Unlocking the Complexity: Exploration of Acute Lymphoblastic Leukemia at the Single Cell Level.

Margo Aertgeerts, Sarah Meyers, Sofie Demeyer

|Mar 18, 2023
Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.

Elien Heylen, Paulien Verstraete, Linde Van Aerschot

|Mar 11, 2023
Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745.

Mirjam Esther van de Velde, Gertjan J L Kaspers, Floor C H Abbink

|Jul 27, 2022
Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.

Mirjam E van de Velde, Aniek Uittenboogaard, Wenjian Yang

|Oct 18, 2021
Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic Leukemia.

Heidi Segers, Jan Cools

Pageof 2

Frequent Collaborators

2 joint publications

Gertjan J L Kaspers

2 joint publications

Mirjam Esther van de Velde

2 joint publications

Jan Cools

1 joint publications

Linea Natalie Toksvang